2024 ESC Guidelines for the management of chronic coronary syndromesChristiaan Vrints, John W. McEvoy, Ronny R. Buechel et al.|European Heart Journal|2024Cited by 2.3k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trialIacopo Olivotto, Amos Katz, Artur Oręziak et al.|The Lancet|2020Cited by 1.2k
Post‐discharge arrhythmic risk stratification of patients with acute myocarditis and life‐threatening ventricular tachyarrhythmiasPiero Gentile, Gianfranco Sinagra, Marco Merlo et al.|European Journal of Heart Failure|2021Cited by 40
Sport PRactice and its Effects on aortic size and valve function in bicuspid Aortic valve Disease: a cross-sectional report from the SPREAD studyFlavio D’Ascenzi, Michael Papadakis, Luna Cavigli et al.|British Journal of Sports Medicine|2024Cited by 9